ChronoScale grants director Davis 51,626 stock units

ChronoScale Holdings Corp (CHRN) director Scott G. Davis acquired 51,626 restricted stock units (RSUs) on October 2, 2026; they vested in full that day.

Rhea-AI Filing Summary

ChronoScale Holdings Corp (CHRN) director Scott G. Davis acquired 51,626 restricted stock units (RSUs) on October 2, 2026; they vested in full that day. Each RSU represents the right to receive one common share, and settlement has been deferred under the award agreement. After the grant, Davis's reported direct holdings were 239,760 shares, with 373 shares held indirectly through a 401(k). The RSUs were granted in connection with the consummation of the disposition of Ekso Bionics, Inc., a wholly owned subsidiary. Davis resigned from the board effective October 3, 2026.

Insider Trade Summary

Grant/Award: 51,626 shares

Grant/Award 2 txns

Insider Davis Scott G.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	51,626	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 239,760 shares (Direct); Common Stock — 373 shares (Indirect, By 401(k))

Footnotes (2)

1. F1. The restricted stock units ("RSUs") were granted on October 2, 2026 in connection with the consummation of the disposition of Ekso Bionics, Inc., a wholly owned subsidiary of ChronoScale Holdings Corporation (the "Issuer"), and vested in full on the grant date. Effective as of October 3, 2026, the Reporting Person resigned as a member of the board of directors of the Issuer. Each RSU represents the right to receive one share of common stock of the Issuer and has no expiration date.
2. F2. Settlement of the RSUs has been deferred in accordance with the terms of the award agreement.

Key Figures

RSUs granted: 51,626 RSUs Shares per RSU: 1 common share per RSU Direct holdings: 239,760 shares +1 more

4 metrics

RSUs granted 51,626 RSUs Granted October 2, 2026; vested in full on the grant date

Shares per RSU 1 common share per RSU Each RSU represents the right to receive one common share

Direct holdings 239,760 shares Reported after the grant

Indirect holdings 373 shares Held by 401(k)

Key Terms

restricted stock units, vested in full, award agreement

3 terms

restricted stock units financial

"restricted stock units ("RSUs") were granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vested in full financial

"vested in full on the grant date"

award agreement financial

"in accordance with the terms of the award agreement"

An award agreement is a legal contract that spells out the terms of a pay or equity grant—such as stock options, restricted shares, or cash bonuses—given to an employee, director or consultant. It describes what is being granted, any conditions for keeping it (for example, earning it over time or meeting performance targets), and what happens if the person leaves or breaks rules. Investors care because these agreements affect company costs, potential share dilution and how executives are motivated and rewarded.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RSUs did CHRN director Scott G. Davis receive?

Davis received 51,626 RSUs on October 2, 2026, and they vested in full that day. Each RSU represents the right to receive one common share, and settlement has been deferred under the award agreement.

When did Scott G. Davis resign from the CHRN board?

Davis's resignation as a member of ChronoScale's board of directors was effective October 3, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/06/2026 - 06:19 PM Accepted by SEC EDGAR 10/06/2026 - 06:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Davis Scott G.

(Last) (First) (Middle)

2440 SAND HILL ROAD,

SUITE 400

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ChronoScale Holdings Corp [ CHRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/02/2026		A		51,626(1)(2)	A	$0	239,760	D
Common Stock								373	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted stock units ("RSUs") were granted on October 2, 2026 in connection with the consummation of the disposition of Ekso Bionics, Inc., a wholly owned subsidiary of ChronoScale Holdings Corporation (the "Issuer"), and vested in full on the grant date. Effective as of October 3, 2026, the Reporting Person resigned as a member of the board of directors of the Issuer. Each RSU represents the right to receive one share of common stock of the Issuer and has no expiration date.

2. Settlement of the RSUs has been deferred in accordance with the terms of the award agreement.

	/s/ Jerome Wong	10/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)